The FDA is on track to release draft guidance on naming biosimilars this year, an FDA official said Wednesday.
Source:: Drug Industry Daily
You are here: Home / Drug Industry News / FDA to Release Four Draft Guidances on Biosimilars This Year
The FDA is on track to release draft guidance on naming biosimilars this year, an FDA official said Wednesday.
Source:: Drug Industry Daily
Leave a Reply